Using these data, we determined that the mbIL–15/IL-15Ra complex expressed by melanoma cells could be cleaved by ADAM17, and thus we treated the melanoma cells with PMA, a powerful activator of ADAM17 (33). Here, IL15RA is linked to melanoma.